DJ Abbott Laboratories Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ slipped 3.42% to $92.72 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.63% to 7,064.01 and Dow Jones Industrial Average falling 0.59% to 49,149.38.
This was the stock's second consecutive day of losses.
Abbott Laboratories closed 33.32% below its 52-week high of $139.06, which the company achieved on June 24th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.96% to $226.16, Pfizer Inc. $(PFE)$ fell 0.76% to $27.31, and Merck & Co. Inc. $(MRK)$ fell 3.88% to $112.56.
Data source: Dow Jones Market Data, FactSet. Data compiled April 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 21, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments